Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
作者信息
Scarffe J H, Wagstaff J, Crowther D
出版信息
Ann Ist Super Sanita. 1987;23(4):777-8.
PMID:3452285
Abstract
摘要
相似文献
1
Clinical use of interferon alfa-2b (intron-A): the Manchester experience.干扰素α-2b（英特龙-A）的临床应用：曼彻斯特的经验。
Ann Ist Super Sanita. 1987;23(4):777-8.
2
INTRON A (interferon alfa-2b): clinical overview.安福隆（干扰素α-2b）：临床概述。
Cancer Treat Rev. 1985 Dec;12 Suppl B:5-16.
3
[Interferons in cancerology. Focus in 1988].
Pathol Biol (Paris). 1989 Feb;37(2):92-3.
4
[Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].α干扰素在肿瘤血液学中的临床应用：结论与展望
Haematologica. 1990 Jul-Aug;75 Suppl 4:82-4.
5
Alfa interferon: combinations with other antineoplastic modalities.α干扰素：与其他抗肿瘤方法的联合应用
Semin Oncol. 1987 Jun;14(2 Suppl 2):48-60.
6
Intron A (interferon alfa-2b): clinical overview and future directions.
Semin Oncol. 1986 Sep;13(3 Suppl 2):89-101.
7
Interferons in the treatment of multiple myeloma.干扰素在多发性骨髓瘤治疗中的应用
Semin Oncol. 1986 Sep;13(3 Suppl 2):13-20.
8
Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.重组干扰素α-2b治疗斑块期蕈样肉芽肿。皮损内及低剂量肌肉注射治疗。
Arch Dermatol. 1987 Jun;123(6):757-63.
9
Interferons and cancer therapy.
J Pathol. 1983 Nov;141(3):287-95. doi: 10.1002/path.1711410308.
10
Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.苯丁酸氮芥与干扰素治疗低度非霍奇金淋巴瘤
Br J Cancer. 1987 Feb;55(2):225-6. doi: 10.1038/bjc.1987.42.
Zotero 插件